May 21, 2025

The Trump administration has rolled out a new vaccine policy that might restrict access to future COVID shots for individuals under the age of 65. This policy, if implemented, could have significant implications on the vaccine distribution and administration process. The decision has stirred debate and concerns among public health experts and the general population, with many questioning the rationale behind such restrictions. The US Food and Drug Administration (FDA) is expected to play a key role in enforcing this new policy. As the COVID-19 vaccination campaign continues, the effectiveness and fairness of these regulations will be closely monitored by various stakeholders and authorities.

Read More at Economictimes →

Tags: Trump, Covid-19, Vaccine policy,